Sign in
8-K

Current Report

Autolus Therapeutics plc Filed Acc 0001193125-26-192362

Exit or restructuring costs · Regulation FD disclosure

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing